Illumina and Veritas Genetics announced a consortium to integrate whole-genome sequencing into preventive healthcare pathways across the U.S. and other markets. Illumina will bring sequencing, DRAGEN pipelines and AI-enabled analytics; Veritas contributes patient-ready myGenome reporting, clinical interpretation and genetic counseling access. The program offers opt-in preventive genomics with confirmatory testing, specialist referral and guideline-aligned screening, and aims to build a consented clinical-genomics dataset for downstream industry partnerships. Illumina framed the alliance as a step toward embedding genomics earlier in care delivery.